13D filed by ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC and 4 other reporting persons reported 14,913,764 shares of ADARx Pharmaceuticals, Inc., 14% of the class, as of 2026-09-28, in a 13D accepted by EDGAR 2026-10-02 21:36:02 UTC.
- Accession
- 0000947871-26-000917
- Filer
- CIK 1055951
- Filed
- 2026-10-02
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Stake
- Subject
- ADARx Pharmaceuticals, Inc.
- Shares
- 14,913,764
- Percent of class
- 14%
- Event date
- 2026-09-28
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group ORBIMED ADVISORS LLC.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | IA | 0 | 14,913,764 | 0 | 14,913,764 | 14,913,764 | 14% |
| ORBIMED CAPITAL GP VII LLC | OO | 0 | 14,325,529 | 0 | 14,325,529 | 14,325,529 | 13.4% |
| ORBIMED ADVISORS ISRAEL II LTD | CO | 0 | 9,292,025 | 0 | 9,292,025 | 9,292,025 | 8.7% |
| ORBIMED ISRAEL GP II, L.P. | PN | 0 | 9,292,025 | 0 | 9,292,025 | 9,292,025 | 8.7% |
| OrbiMed Genesis GP LLC | OO | 0 | 588,235 | 0 | 588,235 | 588,235 | 0.6% |